NELISITOTUG GSK6097608: A DEEP DIVE INTO THE EXPERIMENTAL COMPOUND

Nelisitotug GSK6097608 represents a promising option currently in clinical development for addressing multiple inflammatory ailments. This novel agent shows a distinct action of blocking JAK enzymes, specifically focusing JAK1, which plays a important role in inflammatory signaling. Initial findi